China NMPA Inspection - Wei Yisi Beauty (Wuhan) Co., Ltd. - July 10, 2018

Wei Yisi Beauty (Wuhan) Co., Ltd. was subjected to an unannounced inspection on June 21, 2018, by the State Food and Drug Administration and Hubei Provincial Food and Drug Administration. Conducted under the "Key Points for Cosmetic Production License Inspection," the inspection revealed eight deficiencies, including three serious violations.

The main issues identified were widespread. In quality management, evidence of document alteration and improper handling of substandard products (specifically Zhenmi Brightening Repair Hand Cream) were found. Facility integrity was compromised by damaged floors in the water treatment room and production workshop. Equipment management issues included an emulsification pot pressure gauge with an expired calibration.

Material and product management also presented significant concerns: lack of monitoring for raw materials requiring specific storage, absence of regulations for intermediate product shelf life, and insufficient retained product samples. Production management suffered from a lack of valid labeling for intermediate products.

Consequently, the Hubei Provincial Food and Drug Administration has ordered Wei Yisi Beauty (Wuhan) Co., Ltd. to rectify all identified problems within a specified period. Upon successful completion of these corrective actions, the Hubei Provincial FDA is required to report the findings to the State Food and Drug Administration's Drug and Chemical Supervision Department.